SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Zevra Therapeutics’ 12-Month Price Target Raised to $25.25

Valid market news retained in the public archive without immediate LiveCast distribution.

ZVRA

Related stories